Previous 10 | Next 10 |
2024-01-19 16:59:33 ET Summary Iovance Biotherapeutics is preparing for the extended FDA deadline to determine the approval of lifileucel for advanced melanoma treatment. The FDA has put a clinical hold on the company's Phase II study for LN-145, which has raised concerns about th...
2024-01-18 09:47:08 ET Alibaba Group Holding Ltd (BABA) BABA is trading DOWN for the last 4 days, and it at trading at $68.62 with volume of 6,088,047 and a one day change of $-0.31 (-0.45%). Alibaba Group Holding Ltd has a 52-week low of 67.26 and a 52-week high of $121.30. The bus...
2023-12-29 14:12:19 ET Summary The biotech sector is finishing 2023 on a high after a difficult couple of years, buoyed by Big Pharma M&A activity. The SPDR® S&P Biotech ETF has been soaring as a result of the M&A spree. Despite a challenging year, there have ...
2023-12-28 17:59:00 ET Shares of Iovance Biotherapeutics (NASDAQ: IOVA) popped 18.7% on Thursday as investors assessed the fallout of a clinical hold placed on a cancer-therapy trial yesterday by the U.S. Food and Drug Administration (FDA). Today's rebound nearly recouped an alm...
2023-12-28 12:22:59 ET DENVER, Colo., Dec. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; SEALSQ Corp (NASDAQ: LAES), Microbot Medical Inc (NASDAQ: MBOT), Nova Lifestyle Inc (NASDAQ: NVFY), Se...
2023-12-28 11:01:16 ET More on Iovance Biotherapeutics Iovance Biotherapeutics: The Easiest Money May Have Been Made, But Approval Does Seem Likely Iovance Biotherapeutics, Inc. (IOVA) Q3 2023 Earnings Call Transcript Iovance Biotherapeutics: Testing Shareholders' Pa...
NEW YORK, NY / ACCESSWIRE / December 27, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ:IOVA). Investors who purchased Iovance securities are encouraged to obtain additi...
2023-12-27 12:58:17 ET Gainers: RiskOn International ( ROI ) +175% . Cytokinetics ( CYTK ) +77% . Cingulate ( CING ) +77% . First Wave BioPharma ( FWBI ) +71% . Vince Holding Corp ( VNCE ) +40% . Bakkt Holdings ( BKKT ) ...
2023-12-27 09:07:00 ET U.S. stock index futures on Wednesday pointed to a slightly higher open, a day after equities began the holiday-shortened week on a positive note. Wall Street is looking to extend its massive runup into the end of the year. Here are some stocks to watch on Wednesd...
2023-12-27 08:36:23 ET Iovance Biotherapeutics (NASDAQ: IOVA) stock price suffered a harsh reversal on Wednesday after the company suffered a major setback. The stock, which has been in a strong uptrend, crashed by more than 30% in the pre-market session. It fell to a low of $6.50, whic...
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025 Key Step in Global Expansion to Address >20,000 Patients Annually with Previously Treated Advanced Melanoma SAN CARLOS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, In...
2024-06-28 04:05:00 ET Earlier this year, share prices of Iovance Biotherapeutics (NASDAQ: IOVA) were soaring after one of its therapies obtained approval from regulators. Iovance stock would go on to reach share price highs of more than $18. Today, however, the stock trades at less...
2024-06-20 07:00:08 ET Reni Benjamin from JMP Securities issued a price target of $23.00 for IOVA on 2024-06-20 06:20:00. The adjusted price target was set to $23.00. At the time of the announcement, IOVA was trading at $8. The overall price target consensus is at $23.83...